Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Withdrawn NCT06329414

Acceptability and Feasibility of Transcranial Magnetic Stimulation (TMS) for Depression in Multiple Sclerosis

Conditions: Multiple Sclerosis, Major Depressive Disorder, Treatment Resistant Depression

Sex: All
Ages: 18 Years – 75 Years
Healthy volunteers: No
Sponsor: University of Utah

Location: University of Utah Health Salt Lake City Utah

Summary

The goal of this single-arm, observational pilot study is to learn about the safety, feasibility, preliminary efficacy of TMS for the treatment of depression in people with MS. Participants will receive outpatient TMS treatment over the course of 5-6 weeks. Participants will complete validated questionnaires and exams before, during, and after treatment.

Eligibility Criteria

Inclusion Criteria: * Established diagnosis of multiple sclerosis (any subtype) by 2017 McDonald criteria * Established diagnosis of major depressive disorder (MDD) by DSM-5 criteria * Eligible for transcranial magnetic stimulation (rTMS) for depression Exclusion Criteria: * MS relapse and/or steroid use within 3 months * Active suicidal ideation * History of seizure/epilepsy, brain tumor, or stroke * History of bipolar disorder or psychosis * Currently or planning to become pregnant

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06329414). StuddyBuddy aggregates publicly available trial information.